Skip to main content
OpenTrials
Completed

NCT Number: NCT07205380

GallRiks ERC Anesthesia Study

Endoscopic retrograde cholangiopancreatography (ERCP) for common bile duct stones (CBDS) removal can be performed under varying levels of sedation. Deeper sedation has been associated with more successful cannulation, but little is known about the efficacy of ERCP measured as rate of retained CBDS depending on the level of sedation.

In this population-based, cohort study, using prospectively assembled register data from 121 252 ERCP procedures, adjusted odds ratio (OR) of retained CBDS 12 months after CBDS removal are analysed. Retained CBDS are defined as a repeated ERCP where CBDS are found.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ERCP performed for common bile duct stones

Exclusion criteria

  • Suspicion of bile duct tumour
  • ERCP performed during the seanse as a cholecystectomy
  • Patients having undergone ERCP previously

Treatment and study plan

Endoscopic Retrograde Cholangiopancreaticography

Procedure

Anaesthesia or sedation during ERCP for common bile duct stones

Primary outcomes

  1. Incidence of ERCP for retained stones performed after the primary ERCP.

    Time frame: 12 months

    Retained common bile duct stones necessitating repeated ERCP within 12 months after the first ERCP

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Important dates

Study start
2007
Primary completion
2022
Study completion
2022
First posted
Oct 3, 2025
Registry last updated
Oct 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.